Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing their ability to infiltrate solid tumours.

Diffuse midline gliomas, which primarily affect children ... cord cancer cells produce high levels of a surface marker called GD2. They then went on to show that using GD2-targeting CAR-T cells ...

Although it has been shown that LAT1/4F2hc is highly expressed in a variety of human tumors including gliomas, and LAT1 over-expression is associated with glioma grade and poor prognosis of glioma ...

For one young participant, it eliminated all detectable traces of a typically incurable cancer called diffuse intrinsic ...

Cellares agreed to collaborate with the University of Wisconsin School of Medicine and Public Health to automate the manufacturing of a CRISPR-edited GD2 CAR-T investigational therapy. Company ...